Free Trial
Your $100 Credit Is Waiting! Get MarketBeat All Access Today
Lock In $149
Claim MarketBeat All Access Sale Promotion

Viatris (VTRS) Financials

Viatris logo
$16.30 -0.29 (-1.72%)
As of 11:01 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Viatris

Annual Income Statements for Viatris

This table shows Viatris' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
353 17 -670 -1,269 2,079 55 -634 -3,515
Consolidated Net Income / (Loss)
353 17 -670 -1,269 2,079 55 -634 -3,515
Net Income / (Loss) Continuing Operations
353 17 -670 -1,269 2,079 55 -634 -3,515
Total Pre-Tax Income
298 154 -721 -664 2,813 203 -623 -3,665
Total Operating Income
906 716 -211 -34 1,615 766 10 -2,663
Total Gross Profit
4,002 3,898 3,797 5,576 6,497 6,439 5,624 5,014
Total Revenue
11,434 11,501 11,946 17,886 16,263 15,427 14,739 14,300
Operating Revenue
11,269 11,370 11,820 17,814 16,218 15,388 14,693 14,250
Other Revenue
165 130 126 73 45 39 47 50
Total Cost of Revenue
7,432 7,603 8,149 12,311 9,766 8,988 9,116 9,286
Operating Cost of Revenue
7,432 7,603 8,149 12,311 9,766 8,988 9,116 9,286
Total Operating Expenses
3,096 3,182 4,008 5,610 4,882 5,672 5,614 7,677
Selling, General & Admin Expense
2,441 2,564 3,345 4,529 4,179 4,070 4,105 3,794
Research & Development Expense
705 640 555 751 699 911 837 1,014
Impairment Charge
- - - - - 580 321 2,937
Other Special Charges / (Income)
-50 -21 108 329 4.40 112 351 -69
Total Other Income / (Expense), net
-607 -561 -510 -630 1,198 -563 -633 -1,002
Interest Expense
542 517 498 636 592 573 550 471
Other Income / (Expense), net
-65 -44 -13 5.80 1,791 9.80 -83 -531
Income Tax Expense
-54 138 -51 605 735 148 11 -150
Basic Earnings per Share
$0.69 $0.03 ($1.11) ($1.05) $1.71 $0.05 ($0.53) ($3.00)
Weighted Average Basic Shares Outstanding
514.50M 515.70M 601.20M 1.21B 1.21B 1.20B 0.00 0.00
Diluted Earnings per Share
$0.68 $0.03 ($1.11) ($1.05) $1.71 $0.05 ($0.53) ($3.00)
Weighted Average Diluted Shares Outstanding
516.50M 516.50M 601.20M 1.21B 1.22B 1.21B 0.00 0.00
Weighted Average Basic & Diluted Shares Outstanding
- - 1.21B 1.21B 2.39B 2.38B 1.19B 1.15B
Cash Dividends to Common per Share
- - - $0.33 $0.48 $0.48 $0.48 $0.48

Quarterly Income Statements for Viatris

This table shows Viatris' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
332 -766 114 -326 95 -517 -3,042 -4.60 -128 -340 176
Consolidated Net Income / (Loss)
332 -766 114 -326 95 -517 -3,042 -4.60 -128 -340 176
Net Income / (Loss) Continuing Operations
332 -766 114 -326 95 -517 -3,042 -4.60 -128 -340 176
Total Pre-Tax Income
402 -855 205 -392 91 -527 -3,097 -217 -7.90 -343 -247
Total Operating Income
452 -455 204 -240 226 -180 -2,882 233 179 -193 -80
Total Gross Profit
1,691 1,597 1,504 1,445 1,459 1,215 1,161 1,333 1,372 1,148 1,157
Total Revenue
3,942 3,837 3,663 3,797 3,751 3,528 3,254 3,582 3,760 3,704 3,517
Operating Revenue
3,934 3,826 3,654 3,786 3,738 3,515 3,243 3,569 3,748 3,691 3,510
Other Revenue
8.00 11 9.90 11 13 13 11 13 12 13 7.30
Total Cost of Revenue
2,251 2,241 2,159 2,351 2,292 2,313 2,093 2,249 2,388 2,556 2,360
Operating Cost of Revenue
2,251 2,241 2,159 2,351 2,292 2,313 2,093 2,249 2,388 2,556 2,360
Total Operating Expenses
1,240 2,051 1,300 1,685 1,233 1,395 4,043 1,100 1,193 1,341 1,237
Selling, General & Admin Expense
1,054 1,606 1,018 1,037 1,003 1,047 948 929 887 1,031 929
Research & Development Expense
211 308 200 204 198 229 222 219 250 323 249
Impairment Charge
- - 0.00 321 0.00 - 2,937 0.00 0.00 - 0.00
Other Special Charges / (Income)
-26 148 77 131 32 112 -74 -48 56 -3.10 54
Total Other Income / (Expense), net
-50 -401 0.70 -152 -135 -347 -215 -450 -187 -150 -168
Interest Expense
142 141 138 146 146 120 116 117 120 120 120
Other Income / (Expense), net
92 -260 139 -6.10 10 -227 -99 -334 -67 -31 -48
Income Tax Expense
71 -89 91 -65 -4.30 -10 -55 -213 120 -2.90 -424
Basic Earnings per Share
$0.28 ($0.64) $0.10 ($0.27) $0.08 ($0.44) ($2.55) $0.00 ($0.11) ($0.34) $0.15
Weighted Average Basic Shares Outstanding
1.20B 0.00 1.20B 1.19B 1.19B 0.00 1.19B 1.17B 1.16B 0.00 1.16B
Diluted Earnings per Share
$0.27 ($0.63) $0.09 ($0.27) $0.08 ($0.43) ($2.55) $0.00 ($0.11) ($0.34) $0.15
Weighted Average Diluted Shares Outstanding
1.21B 0.00 1.21B 1.19B 1.20B 0.00 1.19B 1.17B 1.16B 0.00 1.18B
Weighted Average Basic & Diluted Shares Outstanding
1.20B 2.38B 1.19B 1.19B 1.19B 1.19B 1.17B 1.17B 1.15B 1.15B 1.16B
Cash Dividends to Common per Share
$0.12 - $0.12 $0.12 $0.12 - $0.12 $0.12 $0.12 - $0.12

Annual Cash Flow Statements for Viatris

This table details how cash moves in and out of Viatris' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
19 102 359 -144 556 -269 -258 612
Net Cash From Operating Activities
2,342 1,804 1,232 3,017 2,999 2,900 2,303 2,316
Net Cash From Continuing Operating Activities
2,342 1,815 1,232 3,017 2,999 2,900 2,303 2,316
Net Income / (Loss) Continuing Operations
353 17 -670 -1,269 2,079 55 -634 -3,515
Consolidated Net Income / (Loss)
353 17 -670 -1,269 2,079 55 -634 -3,515
Depreciation Expense
2,110 2,019 2,216 4,507 3,028 2,741 2,893 2,798
Non-Cash Adjustments To Reconcile Net Income
333 287 595 909 -1,185 1,203 1,130 4,195
Changes in Operating Assets and Liabilities, net
-453 -508 -910 -1,129 -923 -1,098 -1,086 -1,163
Net Cash From Investing Activities
-1,210 -525 -301 -118 1,474 -865 1,801 -428
Net Cash From Continuing Investing Activities
-1,210 -525 -301 -118 1,474 -865 1,801 -428
Purchase of Property, Plant & Equipment
-252 -213 -243 -457 -406 -377 -326 -379
Acquisitions
-66 -149 416 277 0.00 -668 -350 0.00
Purchase of Investments
-63 -26 -105 -30 -30 -26 -26 -24
Sale of Property, Plant & Equipment
0.00 0.00 2.10 18 14 14 2.70 35
Divestitures
29 28 20 97 1,950 364 2,507 2.50
Sale and/or Maturity of Investments
85 27 47 30 30 26 26 24
Other Investing Activities, net
-944 -193 -438 -52 -83 -198 -33 -86
Net Cash From Financing Activities
-1,091 -1,169 -606 -3,012 -3,878 -2,302 -4,330 -1,294
Net Cash From Continuing Financing Activities
-1,091 -1,169 -606 -3,012 -3,878 -2,302 -4,330 -1,294
Repayment of Debt
-3,232 -1,116 -1,390 -3,821 -5,139 -1,423 -3,423 -192
Repurchase of Common Equity
-432 - - 0.00 0.00 -250 -250 -501
Payment of Dividends
-13 -60 -49 -428 -601 -584 -606 -574
Issuance of Debt
2,578 7.40 983 1,710 1,876 0.30 0.00 0.00
Issuance of Common Equity
- - 0.00 0.00 3.30 3.10 2.50 2.60
Other Financing Activities, net
7.70 -0.30 -151 -473 -17 -48 -53 -30
Effect of Exchange Rate Changes
-21 -7.50 34 -31 -39 -2.50 -31 18
Cash Interest Paid
461 471 555 685 643 612 561 493

Quarterly Cash Flow Statements for Viatris

This table details how cash moves in and out of Viatris' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
680 -318 22 -97 962 -1,144 20 -189 436 345 458
Net Cash From Operating Activities
835 569 615 379 827 483 536 220 745 816 388
Net Cash From Continuing Operating Activities
835 569 615 379 839 470 536 220 745 816 388
Net Income / (Loss) Continuing Operations
332 -766 114 -326 95 -517 -3,042 -4.60 -128 -340 176
Consolidated Net Income / (Loss)
332 -766 114 -326 95 -517 -3,042 -4.60 -128 -340 176
Depreciation Expense
679 644 691 786 670 746 665 678 689 767 676
Non-Cash Adjustments To Reconcile Net Income
-99 1,174 -3.50 499 248 335 3,178 576 196 246 308
Changes in Operating Assets and Liabilities, net
-77 -484 -187 -580 -174 -94 -266 -1,030 -11 144 -773
Net Cash From Investing Activities
-55 27 -154 376 1,748 -169 -65 -53 -99 -211 277
Net Cash From Continuing Investing Activities
-55 27 -154 376 1,735 -156 -65 -53 -99 -211 277
Purchase of Property, Plant & Equipment
-96 -166 -50 -59 -77 -140 -43 -53 -87 -197 -40
Purchase of Investments
-4.30 -5.40 -7.70 -5.60 -8.40 -4.30 -4.60 -6.30 -7.20 -5.80 -7.50
Sale of Property, Plant & Equipment
0.30 0.60 0.70 0.70 0.80 0.50 11 1.60 0.80 21 1.60
Sale and/or Maturity of Investments
4.30 5.40 7.70 5.60 8.40 4.30 4.60 6.30 7.20 5.80 408
Other Investing Activities, net
-7.30 -125 4.20 -3.20 -21 -13 -34 -1.20 -13 -38 -84
Net Cash From Financing Activities
-98 -926 -426 -848 -1,637 -1,420 -467 -362 -228 -236 -204
Net Cash From Continuing Financing Activities
-98 -926 -426 -848 -1,637 -1,420 -467 -362 -228 -236 -204
Repayment of Debt
48 -777 6.20 -679 -1,474 -1,276 -108 -46 -23 -14 -0.30
Repurchase of Common Equity
- - -250 - - - -175 -175 -65 -85 0.00
Payment of Dividends
-144 -144 -154 -166 -143 -143 -155 -142 -140 -138 -148
Issuance of Common Equity
0.80 0.60 0.60 0.70 0.60 0.60 0.60 0.70 0.70 0.60 0.50
Other Financing Activities, net
-2.60 -5.60 -29 -3.40 -21 - -29 -0.20 -0.80 0.10 -57
Effect of Exchange Rate Changes
-2.30 13 -12 -4.40 - - 17 6.70 18 -24 -4.20

Annual Balance Sheets for Viatris

This table presents Viatris' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
31,256 61,553 54,843 50,022 47,686 41,501 37,193
Total Current Assets
6,757 12,868 10,903 10,635 12,976 9,521 9,789
Cash & Equivalents
476 844 701 1,260 992 735 1,322
Accounts Receivable
3,059 4,844 4,266 3,815 3,700 3,221 3,031
Inventories, net
2,671 5,472 3,978 3,520 3,470 3,854 3,999
Prepaid Expenses
552 1,707 1,958 1,811 2,028 1,711 1,436
Plant, Property, & Equipment, net
2,150 3,460 3,189 3,025 2,760 2,666 2,614
Total Noncurrent Assets
22,349 45,226 40,751 36,362 31,950 29,314 24,790
Goodwill
9,591 12,347 12,114 10,426 9,867 9,133 6,755
Intangible Assets
11,650 29,683 26,134 22,607 19,181 17,071 15,102
Noncurrent Deferred & Refundable Income Taxes
703 2,148 1,333 926 693 753 1,061
Other Noncurrent Operating Assets
405 1,048 1,171 2,404 2,209 2,357 1,872
Total Liabilities & Shareholders' Equity
31,256 61,553 54,843 50,022 47,686 41,501 37,193
Total Liabilities
19,372 38,599 34,350 28,950 27,218 22,865 22,482
Total Current Liabilities
5,569 10,563 9,884 6,746 7,777 5,779 7,094
Short-Term Debt
1,508 3,409 3,371 1,259 1,943 8.30 1,933
Accounts Payable
1,528 1,904 1,657 1,767 1,938 1,854 1,754
Current Deferred & Payable Income Tax Liabilities
213 289 237 280 227 193 124
Other Current Liabilities
2,320 4,961 4,620 3,441 3,394 3,725 3,283
Total Noncurrent Liabilities
13,803 28,036 24,466 22,204 19,441 17,086 15,388
Long-Term Debt
11,214 22,429 19,717 18,015 16,188 14,039 12,481
Noncurrent Deferred & Payable Income Tax Liabilities
1,628 3,124 2,815 2,432 1,736 1,108 892
Other Noncurrent Operating Liabilities
961 2,483 1,934 1,757 1,517 1,939 2,015
Total Equity & Noncontrolling Interests
11,884 22,954 20,493 21,072 20,467 18,636 14,711
Total Preferred & Common Equity
12,884 22,954 20,493 23,834 20,719 21,848 15,719
Total Common Equity
11,884 22,954 20,493 23,834 23,215 21,848 14,711
Common Stock
8,650 18,451 18,548 18,658 18,827 18,934 18,814
Retained Earnings
6,031 5,361 3,689 5,176 4,640 3,419 -388
Treasury Stock
-1,000 - - 0.00 -252 -504 -1,007
Accumulated Other Comprehensive Income / (Loss)
-1,797 -858 -1,744 0.00 0.00 0.00 -2,707

Quarterly Balance Sheets for Viatris

This table presents Viatris' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
48,695 48,743 47,686 47,344 45,330 44,754 41,501 38,475 38,412 37,920 36,835
Total Current Assets
9,778 10,932 12,976 12,924 11,792 11,308 9,521 9,622 9,775 9,951 10,917
Cash & Equivalents
629 1,310 992 1,015 917 1,879 735 755 566 975 1,804
Accounts Receivable
3,607 3,739 3,700 3,632 3,567 3,717 3,221 3,126 3,258 3,372 3,076
Inventories, net
3,642 3,672 3,470 3,823 3,942 4,085 3,854 4,096 4,264 4,111 3,927
Prepaid Expenses
1,725 1,785 2,028 1,933 1,757 1,627 1,711 1,645 1,686 1,493 2,109
Plant, Property, & Equipment, net
2,983 2,927 2,760 2,708 2,663 2,677 2,666 2,636 2,643 2,626 2,528
Total Noncurrent Assets
35,934 34,884 31,950 31,712 30,875 30,770 29,314 26,217 25,994 25,343 23,390
Goodwill
10,533 10,278 9,867 9,694 9,326 9,562 9,133 6,462 6,748 6,731 6,692
Intangible Assets
22,084 21,281 19,181 19,134 18,419 17,979 17,071 16,662 16,324 15,723 14,482
Noncurrent Deferred & Refundable Income Taxes
966 930 693 653 685 763 753 818 924 999 1,109
Other Noncurrent Operating Assets
2,351 2,395 2,209 2,232 2,445 2,466 2,357 2,275 1,998 1,890 1,106
Total Liabilities & Shareholders' Equity
48,695 48,743 47,686 47,344 45,330 44,754 41,501 38,475 38,412 37,920 36,835
Total Liabilities
27,852 27,877 27,218 27,329 25,810 24,962 22,865 22,825 22,841 22,703 22,177
Total Current Liabilities
6,524 6,834 7,777 7,760 7,709 7,512 5,779 5,720 7,133 7,364 6,810
Short-Term Debt
1,358 1,308 1,943 1,898 2,367 1,447 8.30 8.50 1,681 1,952 1,931
Accounts Payable
1,962 1,989 1,938 2,197 1,958 1,926 1,854 1,988 1,783 1,793 1,749
Current Deferred & Payable Income Tax Liabilities
158 207 227 148 118 284 193 93 0.00 0.00 0.00
Other Current Liabilities
3,046 3,316 3,394 3,282 3,234 3,856 3,725 3,630 3,670 3,619 3,130
Total Noncurrent Liabilities
21,328 21,043 19,441 19,570 18,101 17,449 17,086 17,104 15,708 15,339 15,367
Long-Term Debt
17,246 17,077 16,188 16,073 14,731 14,303 14,039 14,178 12,792 12,488 12,414
Noncurrent Deferred & Payable Income Tax Liabilities
2,408 2,319 1,736 1,672 1,574 1,277 1,108 1,083 1,081 1,028 871
Other Noncurrent Operating Liabilities
1,674 1,647 1,517 1,825 1,796 1,869 1,939 1,844 1,835 1,823 2,083
Total Equity & Noncontrolling Interests
20,843 20,866 20,467 20,014 19,520 19,792 18,636 15,650 15,571 15,218 14,658
Total Preferred & Common Equity
21,095 21,117 20,719 20,519 20,024 20,297 19,140 16,330 16,426 16,142 15,665
Total Common Equity
21,095 21,117 23,215 20,014 19,520 19,792 18,636 15,650 15,571 15,218 14,658
Common Stock
18,732 18,773 18,827 18,852 18,866 18,901 18,934 18,973 19,011 18,903 18,677
Retained Earnings
5,369 5,553 4,640 4,608 4,134 4,082 3,419 228 80 -48 -212
Treasury Stock
- - -252 -504 -504 -504 -504 -680 -856 -924 -1,007
Accumulated Other Comprehensive Income / (Loss)
-3,006 -3,209 0.00 -2,941 -2,975 -2,686 -3,213 -2,871 -2,664 -2,713 -2,800

Annual Metrics And Ratios for Viatris

This table displays calculated financial ratios and metrics derived from Viatris' official financial filings.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - -
Revenue Growth
0.00% 0.58% 3.87% 49.73% -9.08% -5.14% -4.46% -2.98%
EBITDA Growth
0.00% -8.80% -25.95% 124.74% 43.65% -45.34% -19.81% -114.02%
EBIT Growth
0.00% -20.10% -133.26% 87.38% 12,176.60% -77.21% -109.43% -4,262.98%
NOPAT Growth
0.00% -92.72% -289.54% 83.87% 5,113.48% -82.69% -96.58% -26,467.33%
Net Income Growth
0.00% -95.23% -4,087.50% -89.45% 263.79% -97.37% -1,259.42% -454.23%
EPS Growth
0.00% -95.59% -3,800.00% 5.41% 262.86% -97.08% -1,160.00% -466.04%
Operating Cash Flow Growth
0.00% -22.97% -31.71% 144.92% -0.59% -3.30% -20.59% 0.56%
Free Cash Flow Firm Growth
0.00% 0.00% 0.36% 121.05% 3.38% -23.95% -20.46% -27.71%
Invested Capital Growth
0.00% 0.00% 98.70% -10.57% -9.38% -9.68% -8.97% -12.97%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 4.18% -2.78% -0.25% -2.05% 1.24%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 15.77% 38.60% -42.09% 16.99% 33.98%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 96.65% 96.41% -75.02% 80.79% 5.42%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 95.94% -2.61% -72.04% 103.82% -0.49%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 33.94% 158.66% -97.01% 28.20% 4.78%
EPS Q/Q Growth
0.00% 0.00% 0.00% 56.61% 159.09% -96.69% 27.40% 2.91%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 19.25% -10.02% 17.21% 0.64% 16.80%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% -31.78% 515.31% -14.22% -27.05%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% -2.22% 3.80% -6.48% -5.10% -3.06%
Profitability Metrics
- - - - - - - -
Gross Margin
35.00% 33.89% 31.78% 31.17% 39.95% 41.74% 38.15% 35.06%
EBITDA Margin
25.81% 23.40% 16.68% 25.04% 39.56% 22.79% 19.13% -2.77%
Operating Margin
7.92% 6.22% -1.76% -0.19% 9.93% 4.97% 0.07% -18.62%
EBIT Margin
7.35% 5.84% -1.87% -0.16% 20.94% 5.03% -0.50% -22.33%
Profit (Net Income) Margin
3.08% 0.15% -5.61% -7.10% 12.78% 0.35% -4.30% -24.58%
Tax Burden Percent
118.13% 10.88% 92.89% 191.01% 73.89% 26.96% 101.77% 95.90%
Interest Burden Percent
35.49% 22.99% 322.83% 2,356.03% 82.61% 26.15% 851.37% 114.76%
Effective Tax Rate
-18.13% 89.12% 0.00% 0.00% 26.11% 73.04% 0.00% 0.00%
Return on Invested Capital (ROIC)
0.00% 0.65% -0.41% -0.05% 2.92% 0.56% 0.02% -6.24%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -0.35% -3.21% -5.31% 7.33% -0.38% -4.57% -18.74%
Return on Net Nonoperating Assets (RNNOA)
0.00% -0.36% -3.44% -5.79% 7.08% -0.30% -3.26% -14.84%
Return on Equity (ROE)
0.00% 0.28% -3.85% -5.84% 10.00% 0.26% -3.24% -21.08%
Cash Return on Invested Capital (CROIC)
0.00% -199.35% -66.50% 11.11% 12.76% 10.73% 9.41% 7.63%
Operating Return on Assets (OROA)
0.00% 2.15% -0.48% -0.05% 6.50% 1.59% -0.16% -8.12%
Return on Assets (ROA)
0.00% 0.05% -1.44% -2.18% 3.96% 0.11% -1.42% -8.93%
Return on Common Equity (ROCE)
0.00% 0.28% -3.85% -5.84% 10.67% 0.30% -3.47% -23.11%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.13% -2.92% -6.19% 8.72% 0.26% -3.31% 0.00%
Net Operating Profit after Tax (NOPAT)
1,070 78 -148 -24 1,193 207 7.07 -1,864
NOPAT Margin
9.36% 0.68% -1.24% -0.13% 7.34% 1.34% 0.05% -13.04%
Net Nonoperating Expense Percent (NNEP)
0.00% 1.00% 2.81% 5.26% -4.41% 0.94% 4.59% 12.50%
Return On Investment Capital (ROIC_SIMPLE)
- - - - 2.96% 0.54% 0.02% -6.40%
Cost of Revenue to Revenue
65.00% 66.11% 68.22% 68.83% 60.05% 58.26% 61.85% 64.94%
SG&A Expenses to Revenue
21.35% 22.29% 28.00% 25.32% 25.70% 30.14% 30.03% 26.53%
R&D to Revenue
6.16% 5.56% 4.65% 4.20% 4.30% 5.90% 5.68% 7.09%
Operating Expenses to Revenue
27.08% 27.67% 33.55% 31.36% 30.02% 36.77% 38.09% 53.68%
Earnings before Interest and Taxes (EBIT)
841 672 -223 -28 3,406 776 -73 -3,194
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
2,951 2,691 1,993 4,478 6,433 3,517 2,820 -395
Valuation Ratios
- - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 0.00 0.73 0.52 0.54 0.80 0.97
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.00 0.00 0.00 0.84 0.76 0.81 1.01 1.00
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 5.95 228.14 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 2.67% 4.71% 4.61% 3.86% 3.86%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 16.82% 0.44% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 0.52 0.87 0.78 0.84 0.88 0.99
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 2.09 2.09 1.87 1.92 1.91 1.92
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 12.54 8.34 4.72 8.42 9.99 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 8.92 38.17 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 25.46 143.39 3,984.81 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 20.29 12.38 10.13 10.21 12.23 11.84
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 7.40 5.82 7.47 8.93 12.03
Leverage & Solvency
- - - - - - - -
Debt to Equity
0.00 1.07 1.13 1.13 0.91 0.89 0.75 0.98
Long-Term Debt to Equity
0.00 0.94 0.98 0.96 0.85 0.79 0.75 0.85
Financial Leverage
0.00 1.03 1.07 1.09 0.97 0.78 0.71 0.79
Leverage Ratio
0.00 2.63 2.66 2.68 2.52 2.35 2.28 2.36
Compound Leverage Factor
0.00 0.60 8.60 63.12 2.08 0.62 19.42 2.71
Debt to Total Capital
0.00% 51.70% 52.96% 52.98% 47.77% 46.97% 42.98% 49.49%
Short-Term Debt to Total Capital
0.00% 6.13% 6.99% 7.73% 3.12% 5.03% 0.03% 6.64%
Long-Term Debt to Total Capital
0.00% 45.58% 45.97% 45.24% 44.65% 41.94% 42.96% 42.85%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 48.30% 47.04% 47.02% 59.07% 60.14% 57.02% 50.51%
Debt to EBITDA
0.00 4.73 12.97 5.16 3.00 5.16 4.98 -36.45
Net Debt to EBITDA
0.00 4.55 12.54 5.00 2.80 4.87 4.72 -33.11
Long-Term Debt to EBITDA
0.00 4.17 11.26 4.40 2.80 4.60 4.98 -31.56
Debt to NOPAT
0.00 163.42 -175.11 -970.07 16.15 87.78 1,986.87 -7.73
Net Debt to NOPAT
0.00 157.31 -169.38 -940.61 15.10 82.98 1,882.94 -7.02
Long-Term Debt to NOPAT
0.00 144.05 -152.00 -828.45 15.10 78.37 1,985.70 -6.70
Altman Z-Score
0.00 0.00 0.35 0.70 1.04 0.92 0.96 0.56
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% -6.64% -13.26% -7.03% -9.63%
Liquidity Ratios
- - - - - - - -
Current Ratio
0.00 1.21 1.22 1.10 1.58 1.67 1.65 1.38
Quick Ratio
0.00 0.63 0.54 0.50 0.75 0.60 0.68 0.61
Cash Flow Metrics
- - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -24,053 -23,965 5,045 5,216 3,967 3,155 2,281
Operating Cash Flow to CapEx
928.88% 846.01% 511.33% 687.38% 764.66% 798.90% 712.31% 673.42%
Free Cash Flow to Firm to Interest Expense
0.00 -46.50 -48.14 7.93 8.80 6.92 5.74 4.84
Operating Cash Flow to Interest Expense
4.32 3.49 2.47 4.74 5.06 5.06 4.19 4.91
Operating Cash Flow Less CapEx to Interest Expense
3.85 3.07 1.99 4.05 4.40 4.43 3.60 4.18
Efficiency Ratios
- - - - - - - -
Asset Turnover
0.00 0.37 0.26 0.31 0.31 0.32 0.33 0.36
Accounts Receivable Turnover
0.00 3.76 3.02 3.93 4.03 4.11 4.26 4.57
Inventory Turnover
0.00 2.85 2.00 2.61 2.61 2.57 2.49 2.37
Fixed Asset Turnover
0.00 5.35 4.26 5.38 5.24 5.33 5.43 5.42
Accounts Payable Turnover
0.00 4.98 4.75 6.91 5.70 4.85 4.81 5.15
Days Sales Outstanding (DSO)
0.00 97.08 120.73 92.95 90.68 88.90 85.70 79.80
Days Inventory Outstanding (DIO)
0.00 128.22 182.35 140.08 140.11 141.91 146.63 154.34
Days Payable Outstanding (DPO)
0.00 73.36 76.86 52.80 63.99 75.22 75.92 70.90
Cash Conversion Cycle (CCC)
0.00 151.94 226.22 180.24 166.80 155.59 156.41 163.23
Capital & Investment Metrics
- - - - - - - -
Invested Capital
0.00 24,131 47,948 42,879 38,856 35,096 31,948 27,803
Invested Capital Turnover
0.00 0.95 0.33 0.39 0.40 0.42 0.44 0.48
Increase / (Decrease) in Invested Capital
0.00 24,131 23,818 -5,069 -4,023 -3,760 -3,148 -4,145
Enterprise Value (EV)
0.00 0.00 24,994 37,360 30,375 29,619 28,173 27,431
Market Capitalization
0.00 0.00 0.00 14,974 12,361 12,479 14,860 14,340
Book Value per Share
$0.00 $23.04 $229,541,000.00 $16.94 $19.65 $19.35 $15.61 $12.77
Tangible Book Value per Share
$0.00 ($18.14) ($190,761,000.00) ($14.68) ($7.59) ($4.86) ($6.34) ($6.20)
Total Capital
0.00 24,606 48,793 43,580 40,347 38,599 32,683 29,125
Total Debt
0.00 12,722 25,839 23,088 19,274 18,132 14,047 14,414
Total Long-Term Debt
0.00 11,214 22,429 19,717 18,015 16,188 14,039 12,481
Net Debt
0.00 12,247 24,994 22,386 18,014 17,140 13,312 13,092
Capital Expenditures (CapEx)
252 213 241 439 392 363 323 344
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 2,221 4,870 3,688 3,888 6,150 3,015 3,306
Debt-free Net Working Capital (DFNWC)
0.00 2,696 5,714 4,389 5,148 7,142 3,750 4,628
Net Working Capital (NWC)
0.00 1,188 2,305 1,019 3,889 5,199 3,741 2,695
Net Nonoperating Expense (NNE)
717 61 522 1,245 -885 152 641 1,651
Net Nonoperating Obligations (NNO)
0.00 12,247 24,994 22,386 17,784 14,629 13,312 13,092
Total Depreciation and Amortization (D&A)
2,110 2,019 2,216 4,507 3,028 2,741 2,893 2,798
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 19.31% 40.76% 20.62% 23.91% 39.87% 20.45% 23.12%
Debt-free Net Working Capital to Revenue
0.00% 23.45% 47.83% 24.54% 31.66% 46.30% 25.44% 32.37%
Net Working Capital to Revenue
0.00% 10.33% 19.29% 5.69% 23.91% 33.70% 25.38% 18.85%
Earnings Adjustments
- - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 ($1.11) ($1.05) $1.71 $0.05 ($0.53) ($3.00)
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 601.20M 1.21B 1.21B 0.00 0.00 0.00
Adjusted Diluted Earnings per Share
$0.00 $0.00 ($1.11) ($1.05) $1.71 $0.05 ($0.53) ($3.00)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 601.20M 1.21B 1.22B 0.00 0.00 0.00
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 1.21B 1.21B 2.39B 2.38B 1.19B 1.15B
Normalized Net Operating Profit after Tax (NOPAT)
599 486 -72 207 1,196 614 253 144
Normalized NOPAT Margin
5.24% 4.22% -0.60% 1.16% 7.36% 3.98% 1.71% 1.00%
Pre Tax Income Margin
2.61% 1.34% -6.04% -3.71% 17.30% 1.32% -4.23% -25.63%
Debt Service Ratios
- - - - - - - -
EBIT to Interest Expense
1.55 1.30 -0.45 -0.04 5.75 1.35 -0.13 -6.78
NOPAT to Interest Expense
1.97 0.15 -0.30 -0.04 2.01 0.36 0.01 -3.96
EBIT Less CapEx to Interest Expense
1.09 0.89 -0.93 -0.73 5.09 0.72 -0.72 -7.51
NOPAT Less CapEx to Interest Expense
1.51 -0.26 -0.78 -0.73 1.35 -0.27 -0.58 -4.69
Payout Ratios
- - - - - - - -
Dividend Payout Ratio
3.55% 358.93% -7.24% -33.69% 28.89% 1,067.64% -95.60% -16.34%
Augmented Payout Ratio
126.10% 358.93% -7.24% -33.69% 28.89% 1,524.68% -135.02% -30.58%

Quarterly Metrics And Ratios for Viatris

This table displays calculated financial ratios and metrics derived from Viatris' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 1,151,392,922.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 1,151,392,922.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.15
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-3.34% -1.00% -1.76% -3.11% -4.84% -8.06% -11.17% -5.65% 0.23% 4.97% 8.07%
EBITDA Growth
-4.46% -102.80% -13.81% -53.56% -25.94% 587.66% -324.06% 6.94% -11.66% 59.87% 123.69%
EBIT Growth
-6.37% -144.19% -26.97% -151.60% -56.58% 43.10% -969.24% 59.15% -52.69% 45.02% 95.73%
NOPAT Growth
-19.77% -129.58% -59.23% -157.37% -36.46% 60.44% -1,877.41% 197.12% -47.11% -7.17% 97.23%
Net Income Growth
-6.41% -175.71% -49.31% -223.64% -71.41% 32.54% -2,770.76% 98.59% -235.23% 34.15% 105.80%
EPS Growth
-6.90% -175.90% -52.63% -222.73% -70.37% 31.75% -2,933.33% 100.00% -237.50% 20.93% 105.88%
Operating Cash Flow Growth
-3.89% 200.79% -36.72% -27.80% -1.04% -15.09% -12.87% -42.05% -9.87% 69.01% -27.49%
Free Cash Flow Firm Growth
-95.96% -11.38% 167.13% 952.94% 1,373.79% -12.20% -22.60% 6.36% 24.56% 32.69% -49.03%
Invested Capital Growth
0.25% -9.68% -11.53% -12.09% -10.30% -8.97% -16.16% -13.62% -14.80% -12.97% -6.48%
Revenue Q/Q Growth
0.59% -2.65% -4.53% 3.64% -1.20% -5.95% -7.76% 10.07% 4.96% -1.50% -5.04%
EBITDA Q/Q Growth
5.13% -105.70% 1,583.50% -47.75% 67.65% -62.48% -781.61% 124.94% 38.49% -32.09% 1.01%
EBIT Q/Q Growth
14.06% -231.34% 148.03% -171.72% 195.98% -272.09% -633.82% 96.63% 211.14% -300.00% 43.06%
NOPAT Q/Q Growth
27.23% -185.43% 135.68% -247.94% 240.91% -153.19% -1,503.00% 108.08% -23.26% -207.77% 58.64%
Net Income Q/Q Growth
25.61% -330.88% 114.88% -386.57% 129.04% -644.83% -488.96% 99.85% -2,686.96% -165.29% 151.87%
EPS Q/Q Growth
22.73% -333.33% 114.29% -400.00% 129.63% -637.50% -493.02% 100.00% 0.00% -209.09% 144.12%
Operating Cash Flow Q/Q Growth
59.06% -31.93% 28.20% -38.32% 118.02% -41.60% 10.94% -58.97% 239.05% 9.52% -52.40%
Free Cash Flow Firm Q/Q Growth
-35.25% 1,137.24% 34.59% -2.34% -9.38% -26.29% 18.64% 34.20% 6.13% -21.48% -54.43%
Invested Capital Q/Q Growth
-3.32% -6.48% -1.17% -1.61% -1.35% -5.10% -8.97% 1.36% -2.70% -3.06% -2.18%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
42.91% 41.60% 41.05% 38.07% 38.90% 34.44% 35.68% 37.21% 36.48% 30.99% 32.90%
EBITDA Margin
31.03% -1.82% 28.23% 14.23% 24.15% 9.63% -71.19% 16.13% 21.28% 14.67% 15.61%
Operating Margin
11.46% -11.84% 5.57% -6.32% 6.02% -5.10% -88.57% 6.50% 4.76% -5.20% -2.27%
EBIT Margin
13.79% -18.61% 9.36% -6.48% 6.29% -11.52% -91.62% -2.81% 2.97% -6.03% -3.62%
Profit (Net Income) Margin
8.41% -19.95% 3.11% -8.60% 2.53% -14.64% -93.48% -0.13% -3.41% -9.18% 5.02%
Tax Burden Percent
82.45% 89.54% 55.67% 83.31% 104.75% 98.10% 98.22% 2.12% 1,622.78% 99.15% -71.33%
Interest Burden Percent
73.97% 119.73% 59.65% 159.27% 38.33% 129.58% 103.87% 216.02% -7.07% 153.54% 194.42%
Effective Tax Rate
17.55% 0.00% 44.33% 0.00% -4.75% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
3.90% -3.46% 1.29% -1.85% 2.67% -1.57% -27.86% 2.02% 1.51% -1.74% -0.82%
ROIC Less NNEP Spread (ROIC-NNEP)
3.66% -6.22% 1.29% -2.82% 1.74% -4.36% -35.16% 0.84% -0.35% -3.30% 0.97%
Return on Net Nonoperating Assets (RNNOA)
3.19% -4.85% 1.04% -2.28% 1.31% -3.12% -27.70% 0.69% -0.27% -2.61% 0.83%
Return on Equity (ROE)
7.09% -8.31% 2.33% -4.13% 3.97% -4.69% -55.57% 2.71% 1.24% -4.35% 0.01%
Cash Return on Invested Capital (CROIC)
1.72% 10.73% 11.21% 12.79% 10.33% 9.41% 10.82% 8.89% 10.03% 7.63% 7.04%
Operating Return on Assets (OROA)
4.38% -5.88% 2.98% -2.10% 2.03% -3.81% -30.60% -0.95% 1.02% -2.19% -1.40%
Return on Assets (ROA)
2.67% -6.30% 0.99% -2.79% 0.81% -4.84% -31.22% -0.04% -1.17% -3.34% 1.94%
Return on Common Equity (ROCE)
7.14% -9.41% 2.33% -4.15% 4.00% -5.02% -55.57% 2.71% 1.24% -4.77% 0.01%
Return on Equity Simple (ROE_SIMPLE)
8.67% 0.00% -0.27% -3.23% -4.35% 0.00% -23.21% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
372 -318 114 -168 237 -126 -2,018 163 125 -135 -56
NOPAT Margin
9.45% -8.29% 3.10% -4.42% 6.31% -3.57% -62.00% 4.55% 3.33% -3.64% -1.59%
Net Nonoperating Expense Percent (NNEP)
0.23% 2.76% 0.00% 0.97% 0.93% 2.80% 7.29% 1.18% 1.85% 1.55% -1.79%
Return On Investment Capital (ROIC_SIMPLE)
- -0.82% - - - -0.39% -6.76% 0.54% 0.42% -0.46% -0.19%
Cost of Revenue to Revenue
57.09% 58.40% 58.95% 61.93% 61.10% 65.56% 64.32% 62.79% 63.52% 69.01% 67.10%
SG&A Expenses to Revenue
26.73% 41.85% 27.77% 35.77% 26.75% 29.67% 29.13% 25.93% 23.58% 27.83% 26.41%
R&D to Revenue
5.36% 8.03% 5.62% 5.38% 5.29% 6.48% 6.82% 6.11% 6.66% 8.72% 7.07%
Operating Expenses to Revenue
31.45% 53.45% 35.49% 44.39% 32.88% 39.53% 124.25% 30.71% 31.72% 36.20% 35.17%
Earnings before Interest and Taxes (EBIT)
544 -714 343 -246 236 -406 -2,982 -101 112 -223 -127
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
1,223 -70 1,034 540 906 340 -2,317 578 800 543 549
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.54 0.54 0.72 0.65 0.70 0.80 0.66 0.67 0.76 0.97 1.06
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.73 0.81 0.93 0.83 0.92 1.01 0.73 0.74 0.82 1.00 1.07
Price to Earnings (P/E)
6.18 228.14 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
5.09% 4.61% 4.02% 4.52% 4.13% 3.86% 5.51% 5.38% 4.85% 3.86% 3.55%
Earnings Yield
16.18% 0.44% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.76 0.84 0.90 0.85 0.82 0.88 0.82 0.83 0.87 0.99 1.03
Enterprise Value to Revenue (EV/Rev)
1.84 1.92 2.04 1.89 1.84 1.91 1.66 1.73 1.77 1.92 1.93
Enterprise Value to EBITDA (EV/EBITDA)
4.68 8.42 9.34 10.57 11.50 9.99 0.00 0.00 0.00 0.00 11.37
Enterprise Value to EBIT (EV/EBIT)
9.14 38.17 48.18 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
38.43 143.39 0.00 0.00 0.00 3,984.81 0.00 0.00 0.00 0.00 287.93
Enterprise Value to Operating Cash Flow (EV/OCF)
11.48 10.21 12.80 12.55 12.12 12.23 10.72 11.81 12.61 11.84 12.96
Enterprise Value to Free Cash Flow (EV/FCFF)
44.04 7.47 7.55 6.18 7.54 8.93 6.91 8.63 8.00 12.03 14.18
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.88 0.89 0.90 0.88 0.80 0.75 0.91 0.93 0.95 0.98 0.98
Long-Term Debt to Equity
0.82 0.79 0.80 0.75 0.72 0.75 0.91 0.82 0.82 0.85 0.85
Financial Leverage
0.87 0.78 0.80 0.81 0.75 0.71 0.79 0.81 0.78 0.79 0.86
Leverage Ratio
2.43 2.35 2.36 2.33 2.30 2.28 2.41 2.39 2.36 2.36 2.48
Compound Leverage Factor
1.80 2.82 1.41 3.71 0.88 2.96 2.50 5.16 -0.17 3.62 4.83
Debt to Total Capital
46.84% 46.97% 47.31% 46.69% 44.31% 42.98% 47.55% 48.17% 48.69% 49.49% 49.46%
Short-Term Debt to Total Capital
3.33% 5.03% 5.00% 6.47% 4.07% 0.03% 0.03% 5.59% 6.58% 6.64% 6.66%
Long-Term Debt to Total Capital
43.51% 41.94% 42.31% 40.23% 40.24% 42.96% 47.52% 42.58% 42.11% 42.85% 42.80%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
53.80% 60.14% 52.69% 53.31% 55.69% 57.02% 52.45% 51.83% 51.31% 50.51% 50.54%
Debt to EBITDA
3.03 5.16 5.36 6.27 6.53 4.98 -26.73 -29.34 -24.11 -36.45 5.81
Net Debt to EBITDA
2.81 4.87 5.06 5.93 5.75 4.72 -25.30 -28.19 -22.48 -33.11 5.08
Long-Term Debt to EBITDA
2.81 4.60 4.80 5.40 5.93 4.98 -26.71 -25.93 -20.85 -31.56 5.03
Debt to NOPAT
24.88 87.78 -47.63 -629.55 -85.03 1,986.87 -6.59 -7.94 -7.78 -7.73 147.00
Net Debt to NOPAT
23.11 82.98 -44.94 -595.78 -74.89 1,882.94 -6.24 -7.63 -7.26 -7.02 128.51
Long-Term Debt to NOPAT
23.11 78.37 -42.60 -542.39 -77.22 1,985.70 -6.58 -7.02 -6.73 -6.70 127.21
Altman Z-Score
0.86 0.82 0.93 0.85 0.92 0.94 0.52 0.72 0.77 0.82 0.93
Noncontrolling Interest Sharing Ratio
-0.63% -13.26% 0.00% -0.62% -0.62% -7.03% 0.00% 0.00% 0.00% -9.63% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.60 1.67 1.67 1.53 1.51 1.65 1.68 1.37 1.35 1.38 1.60
Quick Ratio
0.74 0.60 0.60 0.58 0.74 0.68 0.68 0.54 0.59 0.61 0.72
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
278 3,442 4,633 4,524 4,100 3,022 3,586 4,812 5,107 4,010 1,828
Operating Cash Flow to CapEx
873.64% 344.75% 1,251.73% 652.50% 1,084.65% 345.03% 1,710.86% 428.27% 866.16% 465.37% 1,013.84%
Free Cash Flow to Firm to Interest Expense
1.97 24.43 33.47 31.03 28.16 25.14 31.05 41.27 42.70 33.53 15.22
Operating Cash Flow to Interest Expense
5.90 4.03 4.44 2.60 5.68 4.02 4.64 1.88 6.23 6.82 3.23
Operating Cash Flow Less CapEx to Interest Expense
5.23 2.86 4.09 2.20 5.15 2.85 4.37 1.44 5.51 5.36 2.91
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.32 0.32 0.32 0.32 0.32 0.33 0.33 0.34 0.34 0.36 0.39
Accounts Receivable Turnover
4.37 4.11 4.31 4.25 4.04 4.26 4.24 4.14 3.98 4.57 4.70
Inventory Turnover
2.65 2.57 2.39 2.37 2.33 2.49 2.29 2.18 2.21 2.37 2.38
Fixed Asset Turnover
5.18 5.33 5.37 5.40 5.37 5.43 5.36 5.32 5.33 5.42 5.64
Accounts Payable Turnover
5.67 4.85 4.31 4.59 4.62 4.81 4.32 4.78 4.86 5.15 5.11
Days Sales Outstanding (DSO)
83.46 88.90 84.70 85.92 90.42 85.70 86.06 88.24 91.60 79.80 77.72
Days Inventory Outstanding (DIO)
137.66 141.91 152.49 153.74 156.53 146.63 159.72 167.39 165.39 154.34 153.28
Days Payable Outstanding (DPO)
64.41 75.22 84.61 79.46 79.01 75.92 84.41 76.29 75.05 70.90 71.41
Cash Conversion Cycle (CCC)
156.71 155.59 152.59 160.20 167.94 156.41 161.37 179.34 181.93 163.23 159.60
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
37,527 35,096 34,685 34,125 33,664 31,948 29,081 29,476 28,682 27,803 27,198
Invested Capital Turnover
0.41 0.42 0.42 0.42 0.42 0.44 0.45 0.44 0.45 0.48 0.52
Increase / (Decrease) in Invested Capital
94 -3,760 -4,519 -4,692 -3,864 -3,148 -5,603 -4,649 -4,982 -4,145 -1,883
Enterprise Value (EV)
28,392 29,619 31,280 28,838 27,728 28,173 23,828 24,387 25,006 27,431 28,096
Market Capitalization
11,318 12,479 14,324 12,657 13,857 14,860 10,397 10,481 11,542 14,340 15,555
Book Value per Share
$17.60 $19.35 $16.75 $16.39 $16.58 $15.61 $13.11 $13.27 $13.05 $12.77 $12.73
Tangible Book Value per Share
($8.70) ($4.86) ($7.37) ($6.91) ($6.49) ($6.34) ($6.26) ($6.39) ($6.21) ($6.20) ($5.66)
Total Capital
39,250 38,599 37,985 36,619 35,543 32,683 29,836 30,043 29,657 29,125 29,002
Total Debt
18,384 18,132 17,971 17,099 15,750 14,047 14,186 14,472 14,440 14,414 14,345
Total Long-Term Debt
17,077 16,188 16,073 14,731 14,303 14,039 14,178 12,792 12,488 12,481 12,414
Net Debt
17,075 17,140 16,956 16,181 13,871 13,312 13,431 13,906 13,464 13,092 12,540
Capital Expenditures (CapEx)
96 165 49 58 76 140 31 51 86 175 38
Debt-free, Cash-free Net Working Capital (DFCFNWC)
4,096 6,150 6,047 5,533 3,363 3,015 3,156 3,756 3,564 3,306 4,233
Debt-free Net Working Capital (DFNWC)
5,406 7,142 7,062 6,450 5,242 3,750 3,911 4,322 4,539 4,628 6,038
Net Working Capital (NWC)
4,098 5,199 5,164 4,083 3,795 3,741 3,902 2,641 2,587 2,695 4,107
Net Nonoperating Expense (NNE)
41 447 -0.39 158 142 391 1,024 168 253 205 -232
Net Nonoperating Obligations (NNO)
16,662 14,629 14,670 14,605 13,871 13,312 13,431 13,906 13,464 13,092 12,540
Total Depreciation and Amortization (D&A)
679 644 691 786 670 746 665 678 689 767 676
Debt-free, Cash-free Net Working Capital to Revenue
26.48% 39.87% 39.37% 36.31% 22.35% 20.45% 22.02% 26.61% 25.23% 23.12% 29.07%
Debt-free Net Working Capital to Revenue
34.95% 46.30% 45.97% 42.33% 34.83% 25.44% 27.29% 30.62% 32.14% 32.37% 41.46%
Net Working Capital to Revenue
26.50% 33.70% 33.61% 26.79% 25.22% 25.38% 27.23% 18.71% 18.32% 18.85% 28.20%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.28 ($0.64) $0.10 ($0.27) $0.08 ($0.44) ($2.55) $0.00 ($0.11) ($0.34) $0.15
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 1.20B 1.19B 1.19B 0.00 1.19B 1.17B 1.16B 0.00 1.16B
Adjusted Diluted Earnings per Share
$0.27 ($0.63) $0.09 ($0.27) $0.08 ($0.43) ($2.55) $0.00 ($0.11) ($0.34) $0.15
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 1.21B 1.19B 1.20B 0.00 1.19B 1.17B 1.16B 0.00 1.18B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
1.20B 2.38B 1.19B 1.19B 1.19B 1.19B 1.17B 1.17B 1.15B 1.15B 1.16B
Normalized Net Operating Profit after Tax (NOPAT)
351 -214 156 -76 180 -48 -13 130 164 -137 -18
Normalized NOPAT Margin
8.90% -5.59% 4.27% -2.01% 4.80% -1.35% -0.41% 3.62% 4.37% -3.70% -0.52%
Pre Tax Income Margin
10.20% -22.28% 5.59% -10.32% 2.41% -14.92% -95.17% -6.06% -0.21% -9.26% -7.03%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
3.84 -5.07 2.48 -1.69 1.62 -3.38 -25.81 -0.86 0.93 -1.87 -1.06
NOPAT to Interest Expense
2.63 -2.26 0.82 -1.15 1.63 -1.05 -17.47 1.40 1.05 -1.13 -0.46
EBIT Less CapEx to Interest Expense
3.17 -6.24 2.12 -2.09 1.10 -4.54 -26.08 -1.30 0.21 -3.33 -1.38
NOPAT Less CapEx to Interest Expense
1.96 -3.43 0.47 -1.55 1.10 -2.21 -17.74 0.96 0.33 -2.59 -0.78
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
31.97% 1,067.64% -1,043.67% -94.00% -68.72% -95.60% -16.02% -16.80% -15.70% -16.34% -191.26%
Augmented Payout Ratio
45.62% 1,524.68% -1,489.30% -132.67% -97.02% -135.02% -20.65% -26.90% -26.95% -30.58% -300.91%

Financials Breakdown Chart

Key Financial Trends

Here’s a concise four-year look at Viatris (VTRS) using the provided quarterly cash flow statements, income statements, and balance sheets. The overarching themes are solid cash generation from operations and a persistent net income challenge, underpinned by meaningful leverage and ongoing investing activity.

  • Operating cash flow has remained positive in the 2025 quarters, with Net Cash From Continuing Operating Activities around $816 million in Q4 2025 and about $745 million in Q3 2025, indicating ongoing cash generation from core business activities.
  • Sequential strength in cash flow in the back half of 2025, coupled with relatively modest capital outlays (CapEx around $196.5 million in Q4 2025), suggests potential for meaningful free cash flow in that period.
  • Liquidity remains solid. In 2025, total current assets and liabilities point to a positive working capital position, with current assets near $9.3–9.95 billion and current liabilities around $7.3–7.9 billion across 2025 quarters, yielding a healthy current ratio.
  • Revenue base stays in the multi‑billion range each quarter. For example, Q4 2025 Total Revenue ≈ $3.70 billion, with similar quarterly levels seen in related years. There isn’t a clear, sustained up or down spike across the four-year window.
  • Depreciation and amortization are sizable, providing a notable non‑cash add‑back to net income (e.g., Depreciation Expense around $766.8 million in Q4 2025), which supports operating cash flow.
  • Net income tends to be negative in many quarters. For instance, Q4 2025 Net Income Attributable to Common Shareholders was about -$340 million, and several 2023–2024 quarters show meaningful losses, highlighting earnings volatility.
  • Financing activities have generally used cash in 2025, reflecting debt repayments and shareholder returns (e.g., Net Cash From Financing Activities around -$236 million in Q4 2025 and -$228 million in Q3 2025), which can pressure cash balances over time.
  • Leverage remains substantial. Long‑term debt has trended in the low to mid‑teens of billions (roughly $12.8B–$14.3B across 2024–2025), contributing to ongoing interest expense and a sizable liabilities base.
  • Investing activities are cash‑well outflows in many periods as Viatris funds capex and investments (e.g., Net Cash From Investing Activities around -$211.2 million in Q4 2025, -$98.9 million in Q3 2025, and similar levels in other quarters), reducing cash available for other uses in the near term.

Bottom line for investors: Viatris demonstrates ongoing cash generation from operations and a stable liquidity position, but the company continues to wrestle with net losses and a high debt load. The key questions going forward are whether operating performance can translate into stronger earnings, and whether the balance sheet can further de‑risk through debt reduction or improved cash conversion from investing activities.

05/21/26 08:23 AM ETAI Generated. May Contain Errors.

Viatris Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Viatris' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Viatris' net income appears to be on an upward trend, with a most recent value of -$3.51 billion in 2025, falling from $352.50 million in 2018. The previous period was -$634.20 million in 2024. Check out Viatris' forecast to explore projected trends and price targets.

Viatris' total operating income in 2025 was -$2.66 billion, based on the following breakdown:
  • Total Gross Profit: $5.01 billion
  • Total Operating Expenses: $7.68 billion

Over the last 7 years, Viatris' total revenue changed from $11.43 billion in 2018 to $14.30 billion in 2025, a change of 25.1%.

Viatris' total liabilities were at $22.48 billion at the end of 2025, a 1.7% decrease from 2024, and a 16.1% increase since 2019.

In the past 6 years, Viatris' cash and equivalents has ranged from $475.60 million in 2019 to $1.32 billion in 2025, and is currently $1.32 billion as of their latest financial filing in 2025.

Over the last 7 years, Viatris' book value per share changed from 0.00 in 2018 to 12.77 in 2025, a change of 1,277.3%.



Financial statements for NASDAQ:VTRS last updated on 5/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners